Before now Platelet Rich Plasma (PRP) systems were unable to sustain the mononuclear cell population while eliminating the RBC and neutrophils. However, the advanced gel separator utilized by Tropocells® removes the cells that promote inflammation and catabolism while producing a solution rich in platelets and monocytes. This optimizes healing and growth.
FDA cleared 510(k) Class II medical device: Tropocells PRP is intended for the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient point of care. The PRP is mixed with autograft or allograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK110035